New Perspectives on the Future of Drug Discovery
Constantly changing, overwhelmingly complex and voluminous data can create information paralysis that stands in the way of making profitable decisions. Nerac Analysts have developed novel techniques to analyze data to facilitate timely business decisions. This white paper employs a case study of three biotechnology and three pharmaceutical companies to demonstrate how those techniques can be applied to examining large data sets to measure large and small molecule drug pipeline trends. Nerac's information analysis was applied to non-patent and patent data to reach conclusions about drug development trends.